CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3014% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Long-Term Debt Maturing in Year 1 by Year
Long-Term Debt Maturing in Year 1 ($M)
Cvs Health Long-Term Debt Maturing in Year 1: $4,007M in FY2025, up 12.6% from a year earlier.
Latest, FY2025
4,007
Period ended Dec 31, 2025
Change on a year earlier
+12.6%
3,559 in FY2024
History
8 years
Since FY2018
Sources
1
CVS SEC 10-K (XBRL us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths)
Where the FY2025 figure comes from
Source: CVS SEC 10-K (XBRL us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Cvs Health Long-Term Debt Maturing in Year 1 ($M), annual FY2018–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/debt-mat-y1
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.